BioBridgeX
Log inCompare quotes
Clinical

Central Laboratory Services CROs

Free for buyersNeutral marketplace
Quick answer

A central laboratory is the single CRO lab that runs the same safety, biomarker, and PK testing across every site in a clinical trial, so results are comparable no matter where a patient was dosed. You need one as soon as a multi-site Phase 1 through Phase 3 study starts enrolling. On BioBridgeX, buyers source and compare qualified central lab CROs and contract directly with their chosen supplier.

Central Laboratory Services CROs on BioBridgeX

We are qualifying and publishing Central Laboratory Services CROs now. Tell us what you need and we will match you with vetted vendors, or list your organization to be among the first.

What is Central Laboratory Services and when do you need it?

A central laboratory is the one CRO lab that processes the same set of tests for every patient in your trial, no matter which clinical site drew the blood. Instead of each hospital running safety chemistry and hematology on its own analyzers, samples ship to a single facility (or a tightly harmonized network of them) so that a creatinine value from a site in Warsaw means the same thing as one from a site in Houston. That comparability is the entire reason central labs exist. Local labs are fine for a single-site Phase 1, but the moment you run a multi-site study, differences in instruments, reference ranges, and reagent lots turn local data into noise you cannot pool.

The work is broader than just running assays. A central lab builds and ships the collection kits each visit needs, manages the cold chain and courier logistics, runs the routine safety panels (chemistry, hematology, coagulation, urinalysis), and handles specialty testing: pharmacokinetics, biomarkers, flow cytometry, anti-drug antibody and immunogenicity assays, ECG reading, and increasingly genomic and central imaging coordination. It also owns sample inventory and biorepository storage, flags out-of-range and clinically significant results to investigators, and pushes clean lab data into your EDC and the trial's data flow.

You bring a central lab in during study startup, typically once the protocol is close to final and you know your visit schedule, your endpoints, and roughly how many sites and patients you will run. The earlier you engage them, the better, because kit design, the lab manual, and assay validation all sit on the critical path to first-patient-in. Teams that treat the central lab as an afterthought usually pay for it with site activation delays and amended kits mid-study.

What does a Central Laboratory Services CRO actually do?

Day to day, a central lab CRO is part logistics operation and part analytical lab. Before the first patient enrolls, they translate your protocol into a lab manual and a set of visit-specific kits, validate or transfer the assays your endpoints require, set the reference ranges and alert flags, and integrate their data feed with your EDC and biostatistics pipeline. Kit production and global distribution to dozens or hundreds of sites is a real operational discipline, and it is often where an inexperienced lab struggles first.

Once enrollment starts, the lab receives samples, runs the panels, applies quality control, and returns results inside the turnaround the protocol demands. Safety labs usually need fast turnaround because investigators make dosing and eligibility decisions on them, while PK and biomarker assays may batch over longer windows. The lab also escalates clinically significant abnormalities, manages reflex and repeat testing, tracks specimen chain of custody, and keeps the biorepository organized for future or exploratory analyses. Through the close of the study they support audits, inspection readiness, and the final reconciliation of every sample against the database.

  • Kit design, production, and global distribution matched to your visit schedule
  • Routine safety panels: clinical chemistry, hematology, coagulation, urinalysis
  • Specialty testing: PK, biomarkers, flow cytometry, immunogenicity and anti-drug antibody assays, ECG, and central imaging coordination
  • Cold-chain logistics, courier management, and sample receipt and tracking
  • Reference-range setup, alert flagging, and escalation of clinically significant results
  • Biorepository storage, sample inventory, and chain-of-custody management
  • Data integration into the EDC, query handling, and final sample-to-database reconciliation

How to choose a Central Laboratory Services CRO?

The right central lab depends less on brand and more on whether it fits the shape of your specific trial: where your sites are, which assays your endpoints need, and how fast you need results back. A lab that is excellent for a US-only oncology study may be a poor choice for a study spread across Eastern Europe, Latin America, and Asia, where customs, import permits, and local lab licensing become the hard part. Score candidates against the checklist below, and weight the items that map to your protocol's real risks.

Two things separate a smooth study from a painful one. First, logistics reliability: kits that arrive complete and on time, couriers that hold the cold chain, and a sample-receipt process that does not lose specimens. Second, data and turnaround discipline: results that come back inside the protocol window, clean transfers into your EDC, and honest, fast handling of out-of-range and lost-sample situations. Ask for performance metrics from comparable studies rather than accepting general assurances.

  • Quality and GxP status: GCLP and CLIA/CAP accreditation where applicable, current regulatory inspection history, and a documented quality system
  • Capacity and lead time: kit production and distribution capacity, sample throughput, assay turnaround times, and realistic study-startup timelines
  • Modality and indication fit: validated assays for your endpoints (PK, biomarkers, immunogenicity, flow, ECG, central imaging) and relevant therapeutic-area experience
  • Region and regulatory track record: site coverage and lab network in your geographies, import/export and customs handling, local licensing, and successful FDA/EMA-inspected studies
  • Data quality and integration: EDC integration, transfer formats and frequency, query turnaround, audit-trail integrity, and Part 11 compliance
  • IP and confidentiality: ownership of biomarker and exploratory data, biorepository sample-use terms, and protection of proprietary assays and protocol details

Frequently asked questions

What is the difference between a central lab and a local lab in a clinical trial?
A local lab is the lab at or near each clinical site, used mostly for fast same-day safety results in single-site or early-phase studies. A central lab processes samples from every site through one facility or harmonized network, so values are directly comparable across the whole trial. Multi-site studies almost always use a central lab for endpoint and safety data because pooled data from different local analyzers, reference ranges, and reagent lots is not reliable. Some trials run both: local labs for immediate dosing decisions, central lab for the data of record.
When in a clinical trial should we engage the central lab?
During study startup, ideally once the protocol and visit schedule are close to final. Kit design, the lab manual, assay validation or transfer, and reference-range setup all sit on the critical path to first-patient-in, and they take weeks to months depending on how many specialty assays you need. Engaging late is one of the more common causes of site activation delays and mid-study kit amendments, so it is worth bringing the lab in while the protocol is still being finalized rather than after sites are selected.
What does central laboratory pricing depend on?
Cost is driven by the number of patients and visits, the panels and specialty assays per visit, the number of sites and countries (which drives kit and logistics complexity), required turnaround times, and biorepository storage duration. Specialty assays like PK, biomarkers, and immunogenicity cost far more per sample than routine safety chemistry, and global studies carry heavier logistics and customs overhead than domestic ones. Define your visit schedule, assay list, and country list precisely, then compare quotes from several labs against the same specification rather than asking for a generic per-sample rate.
What accreditations and quality standards should a central lab have?
Look for GCLP compliance for clinical trial laboratory work, plus CLIA certification and CAP accreditation for labs serving US studies, and the equivalent local accreditations in other regions. Specialty assays used for endpoints should be validated and, where the data supports regulatory decisions, run to the appropriate standard. Also confirm a clean recent inspection history with FDA, EMA, or the relevant authority, 21 CFR Part 11 compliance for electronic data, and a documented quality system. Ask which accreditations cover which specific assays, because coverage is not always uniform across a lab's menu.
How does a central lab handle global trials with sites across multiple countries?
Through a network of labs or regional hubs plus a logistics operation that manages couriers, cold chain, import and export permits, customs, and local lab licensing. The hard parts of a global trial are rarely the assays themselves; they are getting kits in and samples out of each country reliably and on time, and keeping results comparable across regional facilities. When evaluating a lab for a global study, weight its track record in your specific countries heavily, and ask about customs delays, sample loss rates, and how it harmonizes results across multiple sites.
Can one central lab cover safety labs, PK, and biomarkers, or do we need separate suppliers?
Many central labs run routine safety panels and a range of specialty assays under one roof, which simplifies logistics and gives you a single sample-management and data thread. But specialized work like complex biomarker panels, advanced flow cytometry, or novel immunogenicity assays is sometimes better placed with a dedicated specialty lab. A common setup is a central lab for safety and core testing plus a specialty partner for esoteric endpoints, with sample routing coordinated between them. Through BioBridgeX you can source both and contract directly with your chosen supplier in one place.

Source Central Laboratory Services with one contract

Compare transparent quotes from qualified Central Laboratory Services CROs, then contract once. Free for buyers.

Compare quotes